Showing 20 of 24 recruiting trials for “autosomal-dominant-polycystic-kidney-disease”
Metabolic Impacts of Ren-Nu: A Dietary Program for Polycystic Kidney Disease
Sapu003 in Advanced mTOR-sensitive Solid Tumors
Phase 2a Study of VX-407 in Participants With ADPKD Who Have a Subset of PKD1 Gene Variants (AGLOW)
Safety, Tolerability and Pharmacokinetics of AZD1613 in Adults With Autosomal Dominant Polycystic Kidney Disease
RecruitingNCT06970028 ↗
Somatosensory Phenotyping of ADPKD
RecruitingNCT07260071 ↗
Hypertension in Children and Young People at Risk of Autosomal Dominant Polycystic Kidney Disease
👨⚕️ Manish Sinha, PhD, MRCP (UK), MRCPCH, King's College London📍 1 site📅 Started Aug 2025View details ↗
A Study to Assess Adverse Events and Effectiveness of IntraVenous Infusions of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Phase 1 Study to Evaluate the Safety and Tolerability of Intravenously Administered PYC-003
Trial of JMKX003142 in Participants With Rapidly Progressive Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Shared Decision Making for Choosing Autosomal DOminant Polycystic Kidney Disease Treatment
Short-term Effects of an SGLT2 Inhibitor on Divalent Ions in Autosomal Dominant Polycystic Kidney Disease
HYDROchlorothiazide to PROTECT Polycystic Kidney Disease Patients and Improve Their Quality of Life
👨⚕️ Prof. dr. R.T. Gansevoort, University Medical Center Groningen📍 12 sites📅 Started Jul 2024View details ↗
Astroscape: A Study of Radiprodil on Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavioral Symptoms in Patients With TSC or FCD Type II
Atorvastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease
Implementation of Metformin theraPy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD)
👨⚕️ Andrew Mallett, MBBS, PhD, Townsville University Hospital📍 49 sites📅 Started Nov 2022View details ↗
RecruitingNCT06759142 ↗
Analysis of Patients With Autosomal Dominant Polycystic Kidney
👨⚕️ Gaetano La Manna, MD, IRCCS Azienda Ospedaliero-Universitaria di Bologna📍 1 site📅 Started Feb 2021View details ↗
RecruitingNCT04630613 ↗
NOX4 and Related Biomarkers in ADPKD
Study of Oral Uremic Toxin Absorbent and Probiotics to Retard the Progression of Chronic Kidney Disease
👨⚕️ Chau chung Wu, Ph.D., National Taiwan University Hospital📍 1 site📅 Started May 2020View details ↗
RecruitingNCT04338048 ↗
Autosomal Dominant Polycystic Kidney Disease (ADPKD) Study
👨⚕️ Lisa Guay-Woodford, MD, Children's Hospital of Philadelphia📍 4 sites📅 Started Oct 2019View details ↗
RecruitingNCT04344769 ↗
Characterization of the Nrf2 Response in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
👨⚕️ Maria V. Irazabal, M.D., Ph.D, Mayo Translational PKD Center, Mayo Clinic📍 1 site📅 Started Oct 2019View details ↗
Page 1 of 2Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →